<?xml version="1.0" ?>
<document id="29046115">
  <sentence id="29046115.s0" text="However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (monocyte chemotaxis), Interleukin (IL)-17A, and tumor necrosis factor (negative regulation of transcription by RNA polymerase II)-Î± promoting bone loss in inflammatory states such as rheumatoid arthritis.">
    <entity charOffset="146-165" id="29046115.s0.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="194-199" id="29046115.s0.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-274" id="29046115.s0.e2" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="29046115.s0.e0" e2="29046115.s0.e1" id="29046115.s0.p0" relation="false"/>
    <pair e1="29046115.s0.e1" e2="29046115.s0.e2" id="29046115.s0.p1" relation="false"/>
  </sentence>
  <sentence id="29046115.s1" text="T cell-produced negative regulation of transcription by RNA polymerase II and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).">
    <entity charOffset="16-73" id="29046115.s1.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="120-139" id="29046115.s1.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="29046115.s1.e0" e2="29046115.s1.e1" id="29046115.s1.p0" relation="false"/>
  </sentence>
</document>
